Related references
Note: Only part of the references are listed.Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial
Gareth J. Morgan et al.
BLOOD (2012)
Advances in Imaging and the Management of Myeloma Bone Disease
Evangelos Terpos et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis Executive summary of recommendations from the American Dental Association Council on Scientific Affairs
John W. Hellstein et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2011)
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Gareth J. Morgan et al.
LANCET ONCOLOGY (2011)
Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study
Giovanni D'Arena et al.
LEUKEMIA & LYMPHOMA (2011)
Pharmacokinetics of clodronate in renal failure
H. Saha et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Gareth J. Morgan et al.
LANCET (2010)
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
Peter Gimsing et al.
LANCET ONCOLOGY (2010)
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
M. A. Dimopoulos et al.
ANNALS OF ONCOLOGY (2009)
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
M. Dimopoulos et al.
LEUKEMIA (2009)
A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma
Pellegrino Musto et al.
CANCER (2008)
Myeloma bone disease: pathophysiology and management
E Terpos et al.
ANNALS OF ONCOLOGY (2005)
Share Paper
